EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

A Non‐Canonical Role for Hepatocyte MLKL in Promoting Mitochondrial Dysfunction and Senescence in the Aging Liver

Sabira Mohammed, Chao Jiang, Travis Pennington, Shylesh Bhaskaran, Phoebe Ohene-Marfo, Kara F Kneuper, Constantin Georgescu, Kamille Pitts, Albert Tran, Zongkai Peng, Amit Singh, Zhibo Yang iD und 10 weitere

Aging Cell · 2026

DOI: 10.1111/acel.70618 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Aging Cell, 2026. Verfasst von Sabira Mohammed und 21 weiteren Autor:innen. Beteiligte Einrichtung: Stephenson Cancer Center, University of Oklahoma Health Campus, Oklahoma City, Oklahoma, USA. Hauptthemen laut MEDLINE: Hepatocytes, Protein Kinases, Cellular Senescence, Liver. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Oklahoma Center for the Advancement of Science and Technology, NIH HHS, NIGMS NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Liver aging is characterized by chronic inflammation and metabolic dysfunction that drive progression of metabolic dysfunction‐associated steatotic liver disease (MASLD). Necroptosis, a pro‐inflammatory form of cell death via the Receptor‐Interacting serine/threonine‐Protein Kinase 1 (RIPK1)‐RIPK3‐Mixed Lineage kinase domain Like pseudokinase (MLKL) pathway, is activated in aging livers, and systemic inhibition of this pathway reduces hepatic inflammation and pathology. The cell type‐specific role of necroptosis in liver aging, however, is unclear. Notably, RIPK3 is suppressed in hepatocytes under metabolic disease, suggesting necroptosis independent functions for MLKL. Here, we show that MLKL is elevated in aged hepatocytes and drives liver aging via a non‐necroptotic mechanism. Using hepatocyte‐specific MLKL‐overexpressing mice (MLKL HepOE ), we find that MLKL overexpression does not induce necroptosis but instead promotes cellular senescence, evidenced by increased p16INK4a and p21WAF1/Cip1 and elevated senescence associated secretory phenotype (SASP). Mechanistically, MLKL induces hepatocyte mitochondrial dysfunction, with impaired respiration, altered mitochondrial dynamics, and increased reactive oxygen species, implicating oxidative stress as a contributing mechanism. This mitochondrial stress is associated with enhanced release of pro‐inflammatory extracellular vesicles (EVs) and induction of senescence in hepatocytes and non‐parenchymal cells. While hepatocytes contribute substantially to total senescent burden by abundance, macrophages emerge as a senescence‐enriched population, indicating amplification of senescence through non‐cell‐autonomous signaling. Collectively, these findings reveal a non‐lethal, non‐necroptotic function of hepatocyte MLKL in promoting liver inflammaging via mitochondrial dysfunction and paracrine senescence signaling, identifying MLKL as a regulator of hepatic aging and a potential therapeutic target in age‐associated liver disease.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HepatocytesProtein KinasesCellular SenescenceLiverAgingMitochondriaAnimalsMiceMice, Inbred C57BLMale

Stichwörter der Autor:innen

MLKLagingfission‐fusionhepatocytelivermitochondriaoxidative stresssenescence

Substanzen

Protein KinasesMLKL protein, mouse

Autor:innen und Institutionen

  • Stephenson Cancer Center, University of Oklahoma Health Campus, Oklahoma City, Oklahoma, USA.
  • Department of Biochemistry & Physiology, University of Oklahoma Health Campus, Oklahoma City, Oklahoma, USA.
  • Aging & Metabolism Research Program, Oklahoma Medical Research Foundation, Oklahoma City, Oklahoma, USA.
  • Genes and Human Disease Research Program, Oklahoma Medical Research Foundation, Oklahoma City, Oklahoma, USA.
  • Division of Digestive Diseases and Nutrition, Department of Medicine, University of Oklahoma Health Campus, Oklahoma City, Oklahoma, USA.
  • Department of Chemistry and Biochemistry, The University of Oklahoma, Norman, Oklahoma, USA.

ORCID-Profile: Zhibo Yang, Sathyaseelan S Deepa

Förderung

  • Oklahoma Center for the Advancement of Science and Technology
  • NIH HHS
  • NIGMS NIH HHS
  • NIA NIH HHS
  • NCI NIH HHS
  • Oklahoma Center for Adult Stem Cell Research
  • Oklahoma Center for the Advancement of Science and Technology (OCAST) Health Research Postdoctoral Fellowship
  • Reynolds Foundation

Zitieren

APA

Mohammed, S., Jiang, C., Pennington, T., Bhaskaran, S., Ohene-Marfo, P., Kneuper, K. F., Georgescu, C., Pitts, K., Tran, A., Peng, Z., Singh, A., Yang, Z., Li, T., Hannafon, B., Houchen, C., Wren, J. D., Yabluchanskiy, A., Galvan, V., Ahsan, N., …, & Deepa, S. S. (2026). A Non‐Canonical Role for Hepatocyte MLKL in Promoting Mitochondrial Dysfunction and Senescence in the Aging Liver. Aging Cell. https://doi.org/10.1111/acel.70618

Vancouver

Mohammed S, Jiang C, Pennington T, Bhaskaran S, Ohene-Marfo P, Kneuper KF, et al. A Non‐Canonical Role for Hepatocyte MLKL in Promoting Mitochondrial Dysfunction and Senescence in the Aging Liver. Aging Cell. 2026. doi:10.1111/acel.70618

BibTeX
@article{Mohammed2026,
  author = {Mohammed, Sabira and Jiang, Chao and Pennington, Travis and Bhaskaran, Shylesh and Ohene-Marfo, Phoebe and Kneuper, Kara F and Georgescu, Constantin and Pitts, Kamille and Tran, Albert and Peng, Zongkai and Singh, Amit and Yang, Zhibo and Li, Tiangang and Hannafon, Bethany and Houchen, Courtney and Wren, Jonathan D and Yabluchanskiy, Andriy and Galvan, Veronica and Ahsan, Nagib and Kinter, Michael and Lewis, Tommy L and Deepa, Sathyaseelan S},
  title = {A Non‐Canonical Role for Hepatocyte MLKL in Promoting Mitochondrial Dysfunction and Senescence in the Aging Liver},
  journal = {Aging Cell},
  year = {2026},
  doi = {10.1111/acel.70618}
}
Kostenlos starten →